Loading...
Keywords
Last Name
Institution

Joy Fulbright

Concepts (147)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasms
8
2022
126
2.600
Why?
Rabies Vaccines
2
2016
2
1.080
Why?
Purpura, Thrombocytopenic, Idiopathic
2
2016
4
1.080
Why?
Medical Oncology
3
2022
18
1.060
Why?
Fertility Preservation
2
2022
7
1.000
Why?
Anthracyclines
3
2016
6
0.950
Why?
Heart
2
2016
16
0.950
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
2019
50
0.910
Why?
Antineoplastic Agents
3
2019
56
0.870
Why?
Health Plan Implementation
2
2020
9
0.860
Why?
Infertility
1
2022
5
0.840
Why?
Primary Health Care
2
2020
41
0.830
Why?
Humans
20
2022
6929
0.750
Why?
Specialization
1
2020
7
0.730
Why?
Heart Diseases
3
2015
19
0.720
Why?
Health Personnel
1
2020
24
0.720
Why?
Leukemia, Myeloid, Acute
2
2011
115
0.710
Why?
Apoptosis
2
2018
49
0.680
Why?
Drug Repositioning
1
2018
3
0.630
Why?
Drug Screening Assays, Antitumor
1
2018
7
0.630
Why?
Adolescent
10
2022
2183
0.620
Why?
Male
12
2021
3367
0.590
Why?
Echocardiography, Three-Dimensional
1
2016
26
0.570
Why?
Acetylcysteine
1
2015
9
0.540
Why?
Magnetic Resonance Imaging
1
2016
122
0.540
Why?
Cardiotonic Agents
1
2015
5
0.540
Why?
Child
9
2022
3348
0.500
Why?
Cardiovascular Diseases
1
2015
49
0.480
Why?
Xanthogranuloma, Juvenile
1
2012
1
0.430
Why?
Brain Neoplasms
1
2012
44
0.410
Why?
Female
7
2022
3534
0.370
Why?
Drug-Related Side Effects and Adverse Reactions
1
2010
39
0.360
Why?
Survivors
4
2016
17
0.340
Why?
Cell Line, Tumor
2
2018
98
0.280
Why?
Heart Failure
2
2020
14
0.280
Why?
Troponin I
2
2016
3
0.270
Why?
Biomarkers
2
2016
132
0.260
Why?
Young Adult
3
2022
641
0.250
Why?
Animals
2
2018
741
0.240
Why?
Reference Standards
1
2022
15
0.210
Why?
Granular Cell Tumor
1
2021
1
0.200
Why?
Lower Extremity
1
2021
5
0.200
Why?
Child, Preschool
2
2016
1562
0.190
Why?
Learning
1
2020
5
0.180
Why?
Educational Status
1
2020
21
0.180
Why?
Lymphoma, T-Cell
1
2019
2
0.180
Why?
Asparaginase
1
2019
12
0.180
Why?
Polyethylene Glycols
1
2019
9
0.180
Why?
Desensitization, Immunologic
1
2019
19
0.170
Why?
Practice Patterns, Physicians'
1
2020
85
0.170
Why?
Echocardiography
2
2020
93
0.160
Why?
High-Throughput Screening Assays
1
2018
4
0.160
Why?
Drug Synergism
1
2018
7
0.160
Why?
Small Molecule Libraries
1
2018
5
0.160
Why?
Pelvic Neoplasms
1
2018
3
0.160
Why?
Organs at Risk
1
2018
3
0.160
Why?
Xenograft Model Antitumor Assays
1
2018
14
0.160
Why?
Cell Survival
1
2018
20
0.160
Why?
Dogs
1
2018
28
0.160
Why?
Counseling
1
2018
26
0.160
Why?
Osteosarcoma
1
2018
19
0.160
Why?
Cell Proliferation
1
2018
58
0.160
Why?
Disease Models, Animal
1
2018
61
0.160
Why?
Adult
4
2020
1199
0.160
Why?
Bone Neoplasms
1
2018
25
0.150
Why?
Dose-Response Relationship, Drug
1
2018
96
0.150
Why?
Treatment Outcome
3
2021
649
0.150
Why?
Peptide Fragments
1
2016
12
0.150
Why?
Natriuretic Peptide, Brain
1
2016
6
0.150
Why?
Mice
1
2018
339
0.140
Why?
Feasibility Studies
1
2016
59
0.140
Why?
Risk Factors
3
2016
490
0.140
Why?
Cardiotoxicity
1
2016
2
0.140
Why?
Cardiomyopathies
1
2016
6
0.140
Why?
Myocytes, Cardiac
1
2015
1
0.130
Why?
Jurkat Cells
1
2015
3
0.130
Why?
Oxidation-Reduction
1
2015
12
0.130
Why?
Mice, SCID
1
2015
13
0.130
Why?
Reactive Oxygen Species
1
2015
9
0.130
Why?
Mice, Inbred BALB C
1
2015
25
0.130
Why?
Antioxidants
1
2015
5
0.130
Why?
Leukocytes, Mononuclear
1
2015
15
0.130
Why?
Oxidative Stress
1
2015
15
0.130
Why?
Leukemia
1
2015
15
0.130
Why?
Rats
1
2015
112
0.130
Why?
Cell Line
1
2015
79
0.130
Why?
Acute Disease
1
2015
77
0.130
Why?
Delivery of Health Care
1
2015
33
0.130
Why?
Ambulatory Care Facilities
1
2015
37
0.130
Why?
Porphyrins
1
2015
1
0.130
Why?
Dermatitis, Phototoxic
1
2015
1
0.130
Why?
Troponin T
1
2015
1
0.130
Why?
Phototherapy
1
2015
2
0.130
Why?
Benzazepines
1
2015
4
0.130
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2015
15
0.130
Why?
Guidelines as Topic
1
2015
11
0.130
Why?
Professionalism
1
2014
1
0.130
Why?
Humanism
1
2014
1
0.130
Why?
Hematology
1
2014
3
0.130
Why?
Education, Medical, Graduate
1
2014
12
0.120
Why?
Radiotherapy, Adjuvant
1
2012
5
0.110
Why?
Infant
1
2016
1449
0.100
Why?
Endocrine System Diseases
1
2011
2
0.100
Why?
Central Nervous System Neoplasms
1
2011
6
0.100
Why?
Growth Disorders
1
2011
25
0.100
Why?
Fertility
1
2011
18
0.100
Why?
Stress, Psychological
1
2011
32
0.100
Why?
Iron Chelating Agents
1
2010
1
0.100
Why?
Razoxane
1
2010
1
0.100
Why?
Delayed-Action Preparations
1
2010
3
0.100
Why?
Drug Carriers
1
2010
2
0.100
Why?
Doxorubicin
1
2010
15
0.090
Why?
Drug Administration Schedule
1
2010
36
0.090
Why?
Drug Dosage Calculations
1
2010
16
0.090
Why?
Disease Progression
1
2010
110
0.090
Why?
Randomized Controlled Trials as Topic
1
2010
57
0.090
Why?
Obesity
1
2011
124
0.090
Why?
Pediatrics
2
2016
183
0.060
Why?
Biopsy
1
2021
63
0.050
Why?
Models, Cardiovascular
1
2020
5
0.050
Why?
Cost-Benefit Analysis
1
2020
27
0.050
Why?
Aged, 80 and over
1
2020
168
0.050
Why?
Practice Guidelines as Topic
1
2020
104
0.040
Why?
Aged
1
2020
411
0.040
Why?
Quality of Life
1
2020
139
0.040
Why?
Prognosis
1
2019
216
0.040
Why?
Middle Aged
1
2020
645
0.040
Why?
Primary Ovarian Insufficiency
1
2018
4
0.040
Why?
Puberty
1
2018
7
0.040
Why?
Missouri
1
2018
77
0.040
Why?
Radiotherapy
1
2016
5
0.030
Why?
Continuity of Patient Care
1
2015
6
0.030
Why?
Needs Assessment
1
2015
18
0.030
Why?
Program Development
1
2015
12
0.030
Why?
Program Evaluation
1
2015
45
0.030
Why?
Erythroblastosis, Fetal
1
2015
2
0.030
Why?
Erythrocyte Transfusion
1
2015
2
0.030
Why?
Hyperbilirubinemia
1
2015
9
0.030
Why?
Emergencies
1
2014
11
0.030
Why?
Age Factors
1
2015
211
0.030
Why?
Diagnosis, Differential
1
2014
78
0.030
Why?
Curriculum
1
2014
22
0.030
Why?
Attitude of Health Personnel
1
2014
43
0.030
Why?
Retrospective Studies
1
2018
1337
0.030
Why?
Surveys and Questionnaires
1
2014
275
0.030
Why?
United States
1
2015
670
0.030
Why?
Infant, Newborn
1
2015
826
0.020
Why?
Fulbright's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_